Technology | Radial Access | February 17, 2017

Medtronic Expands Coronary Portfolio With New Tools for Transradial Approach

Full line of transradial products and comprehensive training programs includes diagnostic catheters, compression devices

February 17, 2017 — Medtronic plc announced that its coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line and several transradial-specific products. Additional products include the DxTerity TRA, InTRAkit access kit and TRAcelet compression device, all of which received U.S. Food and Drug Administration (FDA) clearance and CE (Conformité Européenne) Mark for use in diagnostic cardiac catheterization procedures and percutaneous coronary intervention (PCI). 

The DxTerity and DxTerity TRA Diagnostic Catheters are used to determine whether or not revascularization is necessary in patients with coronary artery disease; the DxTerity TRA Diagnostic Catheters are specifically designed for transradial access and allow for engagement of both coronary arteries without catheter exchange. The InTRAkit access kit enhances the transradial experience by providing several component pieces — ergonomic needles that offer excellent flashback visualization, atraumatic mini-guidewires, as well as tapered introducer sheaths that provide kink resistance and enhanced lubricity for easy insertion. The TRAcelet compression device simplifies pressure reduction post-transradial catheterization by facilitating access site patent hemostasis (i.e., stops bleeding while maintaining radial artery patency).

“The global approval of the DxTerity Diagnostic Catheters, as well as the introduction of the new Medtronic suite of transradial products represents a significant step forward for patients requiring PCI procedures,“ said Sunil Rao, M.D., interventional cardiologist and associate professor of medicine at Duke University, in Durham, N.C.  “It’s increasingly important to have a full suite of products accompanied by robust training to increase physician utilization, improve patient comfort and enable same-day discharge.”

In the United States, Medtronic also launched the Transradial Arc Curriculum, a fully-customizable education and training solution for physicians, staff and administrators to ensure successful adoption of the transradial approach from access to patent hemostasis. The curriculum aims to provide robust clinical training and enhance patient care pathways through a hospital-specific approach to help institutions optimize the delivery of transradial care.

A meta-analysis of randomized studies of the transradial approach generally have found that procedures via the transradial approach (through a patient’s wrist) have been associated with cost savings, reduced mortality and improved safety, with reductions in major bleeding and vascular complications.

The DxTerity and DxTerity TRA Diagnostic Catheters, TRAcelet compression device and the InTRAkit Access Kit are commercially available in the United Staets, as well as throughout Europe. The Transradial Arc Curriculum is only available in the U.S.

For more information: www.medtronic.com

Related Content

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Overlay Init